Accepted for Publication: March 29, 2022.
Published Online: July 7, 2022. doi:10.1001/jamaoncol.2022.1769
Corresponding Author: Urvi A. Shah, MD, Myeloma Service, Memorial Sloan Kettering Cancer Center, 530 E 74th St, New York, NY 10021 (shahu@mskcc.org).
Author Contributions: Drs Shah and Iyengar had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: All authors.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: All authors.
Critical revision of the manuscript for important intellectual content: All authors.
Obtained funding: All authors.
Administrative, technical, or material support: All authors.
Supervision: Iyengar.
Conflict of Interest Disclosures: Dr Shah reported grants from Celgene/BMS and Janssen to her institution and personal fees from MJH Life Sciences, Association of Community Cancer Centers, MashUp MD, and Janssen Biotech outside the submitted work. Dr Iyengar reported grants from Novartis to his institution and personal fees from Novartis and Seattle Genetics outside the submitted work.
Funding/Support: Drs Shah and Iyengar are supported by the National Institutes of Health/National Cancer Institute Memorial Sloan Kettering Cancer Center Support grant P30 CA008748 and participated in the TREC Training Workshop (grant R25CA203650). Dr Shah is supported by research grants from International Myeloma Society Career Development Award, Paula and Rodger Riney Foundation, the Allen Foundation Inc, the HealthTree Foundation, the Parker Institute of Cancer Immunotherapy, and the National Cancer Institute MSK Paul Calabresi Career Development Award for Clinical Oncology (grant K12CA184746) to her institution. Dr Iyengar is supported by research grants from National Institutes of Health/National Cancer Institute (R01 CA235711, R01 CA241409), the American Cancer Society (Research Scholar Grant), the Breast Cancer Research Foundation, Novartis, and Kat’s Ribbon of Hope to his institution.
Role of the Funder/Sponsor: The funding organizations had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
3.Key
TJ , Appleby
PN , Crowe
FL , Bradbury
KE , Schmidt
JA , Travis
RC . Cancer in British vegetarians: updated analyses of 4998 incident cancers in a cohort of 32,491 meat eaters, 8612 fish eaters, 18,298 vegetarians, and 2246 vegans.
Am J Clin Nutr. 2014;100(suppl 1):378S-385S. doi:
10.3945/ajcn.113.071266PubMedGoogle ScholarCrossref 4.Kane-Diallo
A , Srour
B , Sellem
L ,
et al. Association between a pro plant-based dietary score and cancer risk in the prospective NutriNet-santé cohort.
Int J Cancer. 2018;143(9):2168-2176. doi:
10.1002/ijc.31593PubMedGoogle ScholarCrossref 7.Levine
ME , Suarez
JA , Brandhorst
S ,
et al. Low protein intake is associated with a major reduction in IGF-1, cancer, and overall mortality in the 65 and younger but not older population.
Cell Metab. 2014;19(3):407-417. doi:
10.1016/j.cmet.2014.02.006PubMedGoogle ScholarCrossref 11.Lauby-Secretan
B , Scoccianti
C , Loomis
D , Grosse
Y , Bianchini
F , Straif
K ; International Agency for Research on Cancer Handbook Working Group. Body fatness and cancer—viewpoint of the IARC Working Group.
N Engl J Med. 2016;375(8):794-798. doi:
10.1056/NEJMsr1606602PubMedGoogle ScholarCrossref 17.Klement
RJ , Champ
CE , Kämmerer
U ,
et al. Impact of a ketogenic diet intervention during radiotherapy on body composition: III-final results of the KETOCOMP study for breast cancer patients.
Breast Cancer Res. 2020;22(1):94. doi:
10.1186/s13058-020-01331-5PubMedGoogle ScholarCrossref 19.Freedland
SJ , Allen
J , Jarman
A ,
et al. A randomized controlled trial of a 6-month low-carbohydrate intervention on disease progression in men with recurrent prostate cancer: Carbohydrate and Prostate Study 2 (CAPS2).
Clin Cancer Res. 2020;26(12):3035-3043. doi:
10.1158/1078-0432.CCR-19-3873PubMedGoogle ScholarCrossref 21.Johnston
CS , Tjonn
SL , Swan
PD , White
A , Hutchins
H , Sears
B . Ketogenic low-carbohydrate diets have no metabolic advantage over nonketogenic low-carbohydrate diets.
Am J Clin Nutr. 2006;83(5):1055-1061. doi:
10.1093/ajcn/83.5.1055PubMedGoogle ScholarCrossref 22.Burén
J , Ericsson
M , Damasceno
NRT , Sjödin
A . A ketogenic low-carbohydrate high-fat diet increases LDL cholesterol in healthy, young, normal-weight women: a randomized controlled feeding trial.
Nutrients. 2021;13(3):814. doi:
10.3390/nu13030814PubMedGoogle ScholarCrossref 25.Guevara-Aguirre
J , Balasubramanian
P , Guevara-Aguirre
M ,
et al. Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans.
Sci Transl Med. 2011;3(70):70ra13. doi:
10.1126/scitranslmed.3001845PubMedGoogle ScholarCrossref 26.Allen
NE , Appleby
PN , Davey
GK , Kaaks
R , Rinaldi
S , Key
TJ . The associations of diet with serum insulin-like growth factor I and its main binding proteins in 292 women meat-eaters, vegetarians, and vegans.
Cancer Epidemiol Biomarkers Prev. 2002;11(11):1441-1448.
PubMedGoogle Scholar 30.Youngman
LD , Campbell
TC . Inhibition of aflatoxin B1-induced gamma-glutamyl transpeptidase positive (GGT+) hepatic preneoplastic foci and tumors by low protein diets: evidence that altered GGT+ foci indicate neoplastic potential.
Carcinogenesis. 1992;13(9):1607-1613. doi:
10.1093/carcin/13.9.1607PubMedGoogle ScholarCrossref 32.Kahleova
H , Petersen
KF , Shulman
GI ,
et al. Effect of a low-fat vegan diet on body weight, insulin sensitivity, postprandial metabolism, and intramyocellular and hepatocellular lipid levels in overweight adults: a randomized clinical trial.
JAMA Netw Open. 2020;3(11):e2025454. doi:
10.1001/jamanetworkopen.2020.25454PubMedGoogle ScholarCrossref 33.Grandl
G , Straub
L , Rudigier
C ,
et al. Short-term feeding of a ketogenic diet induces more severe hepatic insulin resistance than an obesogenic high-fat diet.
J Physiol. 2018;596(19):4597-4609. doi:
10.1113/JP275173PubMedGoogle ScholarCrossref 34.Aune
D , Keum
N , Giovannucci
E ,
et al. Whole grain consumption and risk of cardiovascular disease, cancer, and all cause and cause specific mortality: systematic review and dose-response meta-analysis of prospective studies.
BMJ. 2016;353:i2716. doi:
10.1136/bmj.i2716PubMedGoogle ScholarCrossref 35.Bradbury
KE , Appleby
PN , Key
TJ . Fruit, vegetable, and fiber intake in relation to cancer risk: findings from the European Prospective Investigation into Cancer and Nutrition (EPIC).
Am J Clin Nutr. 2014;100(suppl 1):394S-398S. doi:
10.3945/ajcn.113.071357PubMedGoogle ScholarCrossref 50.Shah
U , Derkach
A , Adintori
P ,
et al. P-042: sustained minimal residual disease negativity in multiple myeloma is impacted positively by stool butyrate and healthier plant forward diets.
Clinical Lymphoma Myeloma and Leukemia. 2021;21:S61. doi:
10.1016/S2152-2650(21)02176-5Google ScholarCrossref 51.Chriett
S , Dąbek
A , Wojtala
M , Vidal
H , Balcerczyk
A , Pirola
L . Prominent action of butyrate over β-hydroxybutyrate as histone deacetylase inhibitor, transcriptional modulator and anti-inflammatory molecule.
Sci Rep. 2019;9(1):742. doi:
10.1038/s41598-018-36941-9PubMedGoogle ScholarCrossref 53.Rodrigues
LM , Uribe-Lewis
S , Madhu
B , Honess
DJ , Stubbs
M , Griffiths
JR . The action of β-hydroxybutyrate on the growth, metabolism and global histone H3 acetylation of spontaneous mouse mammary tumours: evidence of a β-hydroxybutyrate paradox.
Cancer Metab. 2017;5:4. doi:
10.1186/s40170-017-0166-zPubMedGoogle ScholarCrossref 56.Bonuccelli
G , Tsirigos
A , Whitaker-Menezes
D ,
et al. Ketones and lactate “fuel” tumor growth and metastasis: Evidence that epithelial cancer cells use oxidative mitochondrial metabolism.
Cell Cycle. 2010;9(17):3506-3514. doi:
10.4161/cc.9.17.12731PubMedGoogle ScholarCrossref 57.Martinez-Outschoorn
UE , Lin
Z , Whitaker-Menezes
D , Howell
A , Sotgia
F , Lisanti
MP . Ketone body utilization drives tumor growth and metastasis.
Cell Cycle. 2012;11(21):3964-3971. doi:
10.4161/cc.22137PubMedGoogle ScholarCrossref 63.Ornish
D , Lin
J , Chan
JM ,
et al. Effect of comprehensive lifestyle changes on telomerase activity and telomere length in men with biopsy-proven low-risk prostate cancer: 5-year follow-up of a descriptive pilot study.
Lancet Oncol. 2013;14(11):1112-1120. doi:
10.1016/S1470-2045(13)70366-8PubMedGoogle ScholarCrossref 64.Parsons
JK , Zahrieh
D , Mohler
JL ,
et al. Effect of a behavioral intervention to increase vegetable consumption on cancer progression among men with early-stage prostate cancer: the MEAL randomized clinical trial.
JAMA. 2020;323(2):140-148. doi:
10.1001/jama.2019.20207PubMedGoogle ScholarCrossref 65.Chlebowski
RT , Aragaki
AK , Anderson
GL ,
et al. Association of low-fat dietary pattern with breast cancer overall survival: a secondary analysis of the Women’s Health Initiative Randomized Clinical Trial.
JAMA Oncol. 2018;4(10):e181212-e181212. doi:
10.1001/jamaoncol.2018.1212PubMedGoogle ScholarCrossref 66.Pierce
JP , Natarajan
L , Caan
BJ ,
et al. Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women’s Healthy Eating and Living (WHEL) randomized trial.
JAMA. 2007;298(3):289-298. doi:
10.1001/jama.298.3.289PubMedGoogle ScholarCrossref 67.Chlebowski
RT , Blackburn
GL , Thomson
CA ,
et al. Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women’s Intervention Nutrition Study.
J Natl Cancer Inst. 2006;98(24):1767-1776. doi:
10.1093/jnci/djj494PubMedGoogle ScholarCrossref 68.Chlebowski
RT , Blackburn
GL , Hoy
MK ,
et al. Survival analyses from the Women’s Intervention Nutrition Study (WINS) evaluating dietary fat reduction and breast cancer outcome.
J Clin Oncol. 2008;26(15)(suppl):522-522. doi:
10.1200/jco.2008.26.15_suppl.522Google ScholarCrossref 69.Yang
YF , Mattamel
PB , Joseph
T ,
et al. Efficacy of low-carbohydrate ketogenic diet as an adjuvant cancer therapy: a systematic review and meta-analysis of randomized controlled trials.
Nutrients. 2021;13(5):1388. doi:
10.3390/nu13051388PubMedGoogle ScholarCrossref 70.Kämmerer
U , Klement
RJ , Joos
FT , Sütterlin
M , Reuss-Borst
M . Low carb and ketogenic diets increase quality of life, physical performance, body composition, and metabolic health of women with breast cancer.
Nutrients. 2021;13(3):1029. doi:
10.3390/nu13031029PubMedGoogle ScholarCrossref 73.Lowe
DA , Wu
N , Rohdin-Bibby
L ,
et al. Effects of time-restricted eating on weight loss and other metabolic parameters in women and men with overweight and obesity: the TREAT randomized clinical trial.
JAMA Intern Med. 2020;180(11):1491-1499. doi:
10.1001/jamainternmed.2020.4153PubMedGoogle ScholarCrossref 76.Wright
N , Wilson
L , Smith
M , Duncan
B , McHugh
P . The BROAD study: A randomised controlled trial using a whole food plant-based diet in the community for obesity, ischaemic heart disease or diabetes.
Nutr Diabetes. 2017;7(3):e256-e256. doi:
10.1038/nutd.2017.3PubMedGoogle ScholarCrossref 78.Kim
H , Caulfield
LE , Garcia-Larsen
V , Steffen
LM , Coresh
J , Rebholz
CM . Plant-based diets are associated with a lower risk of incident cardiovascular disease, cardiovascular disease mortality, and all-cause mortality in a general population of middle-aged adults.
J Am Heart Assoc. 2019;8(16):e012865. doi:
10.1161/JAHA.119.012865PubMedGoogle ScholarCrossref